ALEXION PHARMACEUTIC

ALXN
Delayed Quote. Delayed  - 10/23 04:00:00 pm
121.61USD +1.62%
Prev.119.6700
Open120.4800
High121.9700
Low119.2850
Volume1 333 115
Latest news
2d ago
4d ago
5d ago
6d ago
Chart ALEXION PHARMACEUTICALS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance125125125
Spread/Res.-3,0%-3,0%-2,3%
Spread/Supp.3,0%9,0%21%
Support118112101
Financials
Sales 2020 5 755 M - -
Net income 2020 330 M - -
Net Debt 2020 77,6 M - -
P/E ratio 2020 82,3x
Yield 2020 -
Capitalization 26 654 M 26 654 M -
EV / Sales 2020 4,64x
EV / Sales 2021 3,95x
Nbr of Employees 3 082
Free-Float 91,3%
Company
Alexion Pharmaceuticals, Inc. specializes in the research and development of therapeutic products used in treating hematological and cardiovascular diseases, auto-immune diseases, and cancers.
At the end of 2019, the group had a portfolio of 6 products in clinical development.
Net sales are...

>> Read more
Sector :
Biopharmaceuticals
Calendar :
2020-10-25 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 145,32 $
Last Close Price 121,61 $
Spread / Highest target 43,9%
Spread / Average Target 19,5%
Spread / Lowest Target -3,79%